PROFEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Profen, and when can generic versions of Profen launch?
Profen is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in PROFEN is suprofen. There are four drug master file entries for this compound. Additional details are available on the suprofen profile page.
Summary for PROFEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROFEN at DailyMed |
Recent Clinical Trials for PROFEN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
McMaster University | Phase 2/Phase 3 |
University of Michigan | Phase 2/Phase 3 |
Oakville Trafalgar Memorial Hospital | Phase 2/Phase 3 |
US Patents and Regulatory Information for PROFEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon | PROFENAL | suprofen | SOLUTION/DROPS;OPHTHALMIC | 019387-001 | Dec 23, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |